Document is current

Article History

Received: 9 August 2023

Accepted: 28 March 2024

First Online: 17 April 2024

Declarations

:

: The NOWAC study also has a license from the Norwegian Data Inspectorate (2002/2241). The Regional Committee for Medical and Health Research Ethics in Northern Norway approved the NOWAC study (REK Nord 141/2008), and specifically approved the current study (REK Nord (494702). Informed consent was obtained from all individual participants included in the study. All research was performed in accordance with relevant guidelines and regulations including the Declaration of Helsinki Ethical Principles involving human subjects.

: Informed consent was obtained from all individual participants included in the study.

: Not applicable.

: The authors declare that they have no competing interests that are relevant to the content of this article. Disclaimer: Some of the data in this article are from the Norwegian Women and Cancer (NOWAC) study. The NOWAC is not responsible for the analysis or interpretation of the data presented. This work was supported by UiT The Arctic University of Norway. The funding sources were not involved in the design and conduct of the study; the collection, management, analysis, or interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.